Word

VECTURA V

Status

Registered

Status Code

700

Status Date

Tuesday, February 13, 2018

Serial Number

79204968

Registration Number

5398606

Registration Date

Tuesday, February 13, 2018

Mark Type

3000

Filing Date

Thursday, November 3, 2016

Published for Opposition

Tuesday, November 28, 2017

Trademark Owner History

Vectura Limited - Original Registrant

Classifications

5 Pharmaceutical and biological preparations for medical purposes, namely for the treatment of diseases or conditions of the respiratory system; pharmaceutical and biological preparations for medical purposes, namely the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynaecological conditions; pharmaceutical and biological preparations for medical purposes, namely for the alleviation or prevention of pain or inflammation; pharmaceutical and biological preparations for medical purposes, namely, powders for asthma inhalers; pharmaceutical and biological preparations for medical purposes, namely, powders for transdermal injection for the alleviation or prevention of pain, for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and biological preparations for medical purposes, namely for oral ingestion for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genitourinary system, infections, skin disorders and gynecological conditions; pharmaceutical and biological preparations for medical purposes, namely for topical administration for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and biological preparations for medical purpose, namely, medicaments for inhalation therapy; pharmaceutical and biological preparations for medical purposes, namely, pulmonary delivery compositions for use in facilitating the inhalation of pharmaceuticals, namely, drug delivery agents consisting of compounds that facilitate delivery by inhalation of a wide range of pharmaceuticals; pharmaceutical and biological preparations for medical purpose, namely medicaments for the treatment of erectile dysfunction, medicaments for the treatment of chronic obstructive pulmonary disease, medicaments for the treatment of premature ejaculation, medicaments for the treatment of cystic fibrosis, medicaments for the treatment of female sexual dysfunction, medicaments for the treatment of migraines, medicaments for the treatment of asthma

10 Medical apparatus and instruments, namely drug delivery devices, namely drug delivery systems; inhalers for medical use; metered dose inhalers for medical use; active dry powder inhalers for medical use; passive dry powder inhalers for medical use; nebulisers for respiration therapy; respirators for artificial respiration; parts and fittings for all the aforesaid goods

42 Scientific research, development, design, analysis, testing and investigation relating to medical preparations and drug delivery devices; medical research; research relating to drug delivery devices; research relating to drug formulation; pharmaceutical development; preparation and formulation of pharmaceuticals; device and product testing

The mark consists of the letter "V" made up of 6 oblique lines and a small triangle appearing next to the stylized word "VECTURA".
Color is not claimed as a feature of the mark.

Trademark Events

Dec 22, 2023

New Representative At Ib Received

Feb 13, 2023

Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed

Oct 8, 2022

New Representative At Ib Received

Jul 13, 2018

Final Decision Transaction Processed By Ib

May 23, 2018

Final Disposition Notice Sent To Ib

May 23, 2018

Final Disposition Processed

May 13, 2018

Final Disposition Notice Created, To Be Sent To Ib

Feb 13, 2018

Registered-Principal Register

Dec 8, 2017

Notification Processed By Ib

Nov 28, 2017

Official Gazette Publication Confirmation E-Mailed

Nov 28, 2017

Published For Opposition

Nov 22, 2017

Notification Of Possible Opposition Sent To Ib

Nov 22, 2017

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Nov 8, 2017

Notification Of Notice Of Publication E-Mailed

Oct 20, 2017

Approved For Pub - Principal Register

Oct 11, 2017

Teas/Email Correspondence Entered

Oct 11, 2017

Correspondence Received In Law Office

Oct 11, 2017

Teas Response To Office Action Received

May 13, 2017

Refusal Processed By Ib

Apr 25, 2017

Non-Final Action Mailed - Refusal Sent To Ib

Apr 24, 2017

Refusal Processed By Mpu

Apr 20, 2017

Non-Final Action (Ib Refusal) Prepared For Review

Apr 19, 2017

Non-Final Action Written

Apr 18, 2017

Application Filing Receipt Mailed

Apr 14, 2017

Assigned To Examiner

Apr 14, 2017

New Application Office Supplied Data Entered

Apr 13, 2017

Sn Assigned For Sect 66a Appl From Ib